Last reviewed · How we verify
P-Sam
At a glance
| Generic name | P-Sam |
|---|---|
| Sponsor | M.D. Anderson Cancer Center |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I) (PHASE2)
- Pericapsular Block Versus Trans Muscular Quadratus Lumborum Block in Patients Undergoing Correction of Hip Dysplasia (NA)
- Sumor as Adjuvant Therapy in Treatment-resistant Major Depression (PHASE4)
- Induction and Recognition of Emotions
- Pectoral Nerve Block Type-II and Rhomboid Intercostal Block for Pain Management Following Mastectomy Surgery (NA)
- Evaluation of SAMe for Hot Flashes (PHASE2)
- Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection (PHASE2)
- Efficacy of S-Adenosylmethionine in Fibromyalgia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |